Supernus Pharmaceuticals, Inc.
$37.88
-1.69 (-4.27%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -11.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -22.7%
Own SUPN?
See how SUPN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.